A retrospective study to determine efficacy and safety of mepolizumab and benralizumab in patients with EGPA in real-life settings
Latest Information Update: 03 Feb 2023
At a glance
- Drugs Benralizumab (Primary) ; Mepolizumab (Primary)
- Indications Asthma; Granulomatosis
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2023 New trial record